Search

ZnFe2O4 particles initially synthesized through a simple solvothermal method were coated using polyindole (PIn) to prepare an actively controllable core-shell typed hybrid material under both electric and magnetic fields. An advantage of this process is not needing to add the stabilizers or surfactants commonly used for uniform coating when synthesizing core or shell-structured particles. The synthesized ZnFe2O4/PIn particles have a lower density than conventional magnetic particles and have suitable properties as electrorheological (ER) particles. The expected spherical shape of the particles was proven using both scanning electron microscopy and transmission electron microscopy. The chemical characterization was performed using Fourier-transform infrared spectroscopy and X-ray diffraction analysis. To analyze the rheological properties, a ZnFe2O4/PIn based suspension was prepared, and dynamic rheological measurements were performed for different electric field strengths using a rotary rheometer. Both dynamic and elastic yield stresses of the ER fluid had a slope of 1.5, corresponding to the conductivity model. Excellent ER effect was confirmed through rheological analysis, and the prepared ER fluid had a reversible and immediate response to repeated electric fields.

Magnetic/conducting polymeric hybrid core-shell typed zinc ferrite (ZnFe2O4)/poly(N-methyl aniline) (PMA) particles were fabricated and adopted as electrorheological (ER) and magnetorheological (MR) fluids, and their rheological properties were examined. Solvo-thermally synthesized ZnFe2O4 was coated with a conducting PMA through chemical oxidation polymerization. The size, shape, and chemical composition of the final core-shell shaped particles were scrutinized by scanning electron microscopy, transmission electron microscopy, and Fourier transform-infrared spectroscopy. The crystal faces of the particles before and after coating with PMA were analyzed by X-ray diffraction. The ZnFe2O4/PMA products were suspended in silicone oil to investigate the rheological response to electro- or magnetic stimuli using a rotating rheometer. The shear stresses were analyzed using the CCJ equation. The dynamic yield stress curve was suitable for the conductivity mechanism with a slope of 1.5. When magnetic fields of various intensities were applied, the flow curve was analyzed using the Hershel–Bulkley equation, and the yield stresses had a slope of 1.5. Optical microscopy further showed that the particles dispersed in insulating medium form chain structures under electric and magnetic fields. Via this core-shell fabrication process, not only spherical conducting particles were obtained but also their dual ER and MR responses were demonstrated for their wide potential applications.

Magnetic/conducting polymeric hybrid core-shell typed zinc ferrite (ZnFe

Magnetic zinc ferrite particles synthesized by the solvothermal method were coated with conductive polyaniline, and their electro- and magneto-responsive smart fluid behaviors were investigated. Both size and morphology of the produced particles were identified by SEM and TEM. Their chemical composition and crystal faces were analyzed by FT-IR and X-ray diffraction, respectively. The synthesized particles were suspended in silicone oil at 5 vol%, and their electro- and magneto-responses were scrutinized using a rotation rheometer. In an electric field, the flow curve was fitted smoothly to the CCJ model, and the yield stress showed an exponential value of 1.5. In contrast, an exponential value of 1.0 was observed for the yield stress in a magnetic field.

Malignant glioma is the most frequent type in brain tumors. The prognosis of this tumor has not been significantly improved for the past decades and the average survival of patients is less than one year. Thus, an effective novel therapy is urgently needed. TNF-related apoptosis inducing ligand (TRAIL), known to have tumor cell-specific killing activity, has been investigated as a novel therapeutic for cancers. We have developed Ad-stTRAIL, an adenovirus delivering secretable trimeric TRAIL for gene therapy and demonstrated the potential to treat malignant gliomas. Currently, this Ad-stTRAIL gene therapy is under phase I clinical trial for malignant gliomas. Here, we report preclinical studies for Ad-stTRAIL carried out using rats. We delivered Ad-stTRAIL intracranially and determined its pharmacokinetics and biodistribution. Most Ad-stTRAIL remained in the delivered site and the relatively low number of viral genomes was detected in the opposite site of brain and cerebrospinal fluid. Similarly, only small portion of the viral particles injected was found in the blood plasma and major organs and tissues, probably due to the brain-blood barrier. Multiple administrations did not lead to accumulation of Ad-stTRAIL at the injection site and organs. Repeated delivery of Ad-stTRAIL did not show any serious side effects. Our data indicate that intracranially delivered Ad-stTRAIL is a safe approach, demonstrating the potential as a novel therapy for treating gliomas.